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Abstract Brain inflammation plays a central role in multi-
ple sclerosis (MS). Besides lymphocytes, the astroglia and
microglia mainly contribute to the cellular composition of
the inflammatory infiltrate in MS lesions. Several studies
were able to demonstrate that cortical lesions are character-
ized by lower levels of inflammatory cells among activated
microglia/macrophages. The underlying mechanisms for
this difference, however, remain to be clarified. In the
current study, we compared the kinetics and extent of
microglia and astrocyte activation during early and late
cuprizone-induced demyelination in the white matter
tract corpus callosum and the telencephalic gray matter.
Cellular parameters were related to the expression pro-
files of the chemokines Ccl2 and Ccl3. We are clearly
able to demonstrate that both regions are characterized
by early oligodendrocyte stress/apoptosis with concomi-
tant microglia activation and delayed astrocytosis. The
extent of microgliosis/astrocytosis appeared to be greater
in the subcortical white matter tract corpus callosum
compared to the gray matter cortex region. The same
holds true for the expression of the key chemokines
Ccl2 and Ccl3. The current study defines a model to
study early microglia activation and to investigate dif-
ferences in the neuroinflammatory response of white vs.
gray matter.
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Abbreviations
APC Adenomatous polyposis coli
BBB Blood–brain barrier
CC Corpus callosum
CNPase 2′3′-Cyclic nucleotide 3′-phosphodiesterase
CNS Central nervous system
Cx Cortex
EAE Experimental autoimmune encephalomyelitis
GFAP Glial fibrillary acidic protein
H&E Hematoxylin and eosin stain
HLA Human leukocyte antigen
LFB Kluver–Barrera/luxol fast blue stain
MCP-1 Monocyte chemotactic protein-1 or CCL2




Multiple sclerosis (MS), a chronic inflammatory and demye-
linating disease, was first identified as a separate neurological
disorder by the French neurologist Jean-Martin Charcot and is
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a common disorder of the central nervous system (CNS)
in young adults. Postmortem tissue is widely used to
study which molecular and cellular mechanisms are
involved in MS lesion development. The histopathological
hallmarks of the lesions are inflammation, demyelination,
and axonal degeneration (van der Valk and De Groot 2000;
Frischer et al. 2009). Different types of lesions have been
classified on the histological level, the active ones con-
taining a high number of microglia/macrophages (Barnett
and Prineas 2004; Bitsch et al. 2001). Using general histo-
logical methods such as hematoxylin and eosin (H&E) or
LFB stain in combination with immunohistochemistry
(IHC) for myelin and human leukocyte antigen (HLA)-
DR antigens, lesions can be classified into several stages.
Pre-active lesions contain activated microglial cells
(strongly positive for HLA-DR); however, there is no overt
demyelination (van der Valk and Amor 2009). Active de-
myelinating lesions are hypercellular due to the macro-
phages and/or microglia which are phagocytosing myelin
sheaths, giving them a so-called foamy appearance.
Chronic active lesions contain a hypocellular center and a
hypercellular rim with myelin-containing macrophages, in-
dicating ongoing demyelination at the lesion edge and
complete demyelination with cessation of inflammatory
processes in the center of the lesion. Finally, chronic
inactive lesions are hypocellular, although some residual
inflammatory activity might be present at the borders of
the lesion (van der Valk and De Groot 2000; van der
Valk and Amor 2009). It has been recently reported that
pronounced inflammation in the brain is present not
only in acute and relapsing MS but also in the secondary
and primary progressive disease (Frischer et al. 2009). Thus,
brain inflammation plays a critical role in MS pathogenesis
and disease progression.
Two categories of molecules direct leukocyte migration
and microglia activation into inflammatory sites: adhesion
molecules and cytokines. Among cytokines, chemokines
(small, pro-inflammatory chemotactic cytokines) have
gained particular interest because of their potential role in
pathogenic inflammation (Luster 1998; Baggiolini 1998).
Chemokines possess the ability to induce chemotaxis
(directional migration) and non-directional cell migration
of a variety of cell types, particularly leukocytes (Karpus and
Ransohoff 1998; Sozzani et al. 1996). Furthermore, chemo-
kines have been shown to be important for cell migration in
the absence of inflammation (Patel et al. 2010). Indeed,
chemokines now appear to have multiple biological
activities in addition to their known role in mobilizing
inflammatory cells. Their expression is induced in various
pathologies of the CNS, among Alzheimer’s disease,
Behçet’s disease, HIV-1-associated dementia, human T cell
leukemia virus-1-associated myelopathy, or brain injury
(McMahon et al. 2001; Glabinski et al. 1997). In particular,
chemokines are induced in the demyelinating disease
MS and numerous animal models for demyelination,
including experimental autoimmune encephalomyelitis
(EAE), Theiler’s and hepatitis virus-induced demyelinat-
ing disease, experimental autoimmune neuritis, and
twitcher, a murine model of globoid cell leukodystrophy
(McMahon et al. 2001).
Four subfamilies of chemokines have been classified—C
(γ), CC(β), CXC(α), or CX3C(δ)—according to the num-
ber and spacing between the cysteine residues in the N-
terminal region. They signal via seven G-protein-coupled
transmembrane receptors of the serpentine superfamily
(Hoffman et al. 2001). Most chemokines display affinity
for more than one receptor and elicit biological activities
at nanomolar concentrations in vivo. Differential expression
of a number of chemokines and their receptors has been
demonstrated in both acute and chronic MS lesions,
including monocyte chemotactic protein-1 (MCP-1 or
CCL2) and macrophage inflammatory protein-1α (MIP1α
or CCL3; Szczucinski and Losy 2007). Through construction
of transgenic and knockout mice, much progress has been
made in our understanding of chemokine action in vivo.
Several research groups have used EAE to probe CNS
chemokine expression and function. Karpus and col-
leagues showed that anti-CCL3 antibodies suppress the
initial attack of adoptive-transfer EAE, while anti-CCL2 anti-
bodies inhibit subsequent relapses, indicating that specific
chemokines execute non-redundant functions in these disease
models (Karpus and Ransohoff 1998; Karpus et al. 1995;
Karpus and Kennedy 1997).
In MS, brain inflammation is associated with lesions
appearing typically in plaques within the white matter.
Histopathological studies, however, now convincingly
show that gray matter regions, such as the forebrain
cortex (Cx), are also affected (Geurts and Barkhof
2008; Geurts et al. 2007; Lucchinetti et al. 2011). The
pathology of gray matter lesions differs from white
matter lesions in several aspects, such as less pro-
nounced lymphocyte infiltration, macrophage activity,
complement composition, or blood–brain barrier (BBB)
alterations (Bo et al. 2003; Breij et al. 2008; van
Horssen et al. 2007; Peterson et al. 2001). The observed
differences could be due to the differences in the com-
position and function of the BBB or other elements of
the cytoarchitecture of the cerebral Cx, which makes it
more resistant to inflammation (Bo et al. 2003). Given
the extensive cortical involvement in MS patients, the
low T and B cell infiltration in cortical lesions, and the
extensive white matter demyelination in most MS
patients, it has been proposed that cortical lesions are
degenerative in origin. However, whether or not the
development of cortical demyelinated lesions in MS
displays a separate identity remains to be clarified.
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Comparative analyses are warranted to detect not only
differences but also similarities in the genesis of white
vs. gray matter lesions in MS patients.
As pointed out above, chemokines appear to be crit-
ically involved in the induction of an inflammatory
response during MS lesion formation. The purpose of
this study was to compare the kinetics and extent of
microglia and astrocyte activation during cuprizone-
induced demyelination in the white matter tract corpus
callosum and the telencephalic gray matter. Cellular
parameters were related to the expression profile of the
chemokines Ccl2 and Ccl3 to detect a relationship of neuro-
inflammatory responses and local chemokine levels.
Material and Methods
Animals and Demyelination
C57BL/6J mice were obtained from Charles River
(Germany) and underwent routine cage maintenance once
a week and microbiological monitoring according to the
Federation of European Laboratory Animal Science
Association’s recommendations. Food and water were
available ad libitum. Animal care procedures were ap-
proved by the Review Board for the Care of Animal
Subjects of the district government (Nordrhein-Westfalen,
Germany) and performed according to international guide-
lines on the use of laboratory animals. Demyelination was
induced by feeding 8- to 9-week-old (19–21 g) male mice a
diet containing 0.2 % cuprizone (bis-cyclohexanone
oxaldihydrazone, Sigma-Aldrich Inc., Germany), mixed
into a ground standard rodent chow for the indicated
period as previously described (Clarner et al. 2011; Acs
et al. 2009; Kipp et al. 2011a). Control animals were
fed normal powdered chow.
Tissue Preparation
Tissue preparation was performed as previously described
(Acs et al. 2009; Groebe et al. 2009; Kipp et al. 2008). For
histological and immunohistochemical studies, mice were
transcardially perfused with 2 % paraformaldehyde contain-
ing picric acid. After overnight post-fixation, brains were
dissected, embedded, and then coronary processed into 5-μm
sections from the levels 215 to 275 according to the mouse
brain atlas by Sidman et al. (http://www.hms.harvard.edu/
research/brain/atlas.html). For gene expression analysis, mice
were transcardially perfused with ice-cold PBS, the brains
quickly removed, and the entire corpus callosum without the
adjacent cortex dissected using a stereomicroscopic approach.
Isolated corpus callosi and cortices were snap-frozen in liquid
nitrogen and kept at −80°C until used.
IHC and Cell Parameter Quantification
For IHC, sections were placed on silane-coated slides,
deparaffinized, rehydrated, heat-unmasked, blocked with
PBS containing 5 % normal serum, and incubated overnight
with the primary antibody diluted in blocking solution.
Anti-proteolipid protein antibody (PLP, 1:500, mouse IgG;
Serotec, Germany) was used as a myelin marker; anti-
adenomatous polyposis coli (APC, 1:200, mouse IgG;
Calbiochem, Germany) was used to stain late-stage oli-
godendrocyte cell bodies, while anti-glial fibrillary acid-
ic protein (GFAP, 1:1,000, rabbit IgG; Encore, USA)
was used to visualize astrocytes. Anti-ionized calcium-
binding adaptor molecule antibody (IBA1, 1:250, rabbit
IgG; Wako, Germany) was used as a marker to detect
microglia/macrophages. An antibody against 2′3′-cyclic
nucleotide 3′-phosphodiesterase [anti-CNPase (SMI-91)
mouse monoclonal IgG1, Abcam, UK) was used to
detect oligodendrocytes and myelin fibers and an anti-
active caspase 3 antibody (anti-active caspase 3, 1:250,
rabbit IgG; Abcam) was used to visualize apoptotic
cells (Acs et al. 2009; Kipp et al. 2011a; Norkute et
al. 2009; Dang et al. 2011). After washing and blocking
of endogenous peroxidase with hydrogen peroxide
(0.3 %, 30 min), sections were incubated with biotiny-
lated secondary anti-mouse or anti-rabbit IgG antibodies
(1:50; Vector Laboratories, Burlingame, CA, USA) for
1 h, followed by peroxidase-coupled avidin–biotin com-
plex (ABC kit, Vector Laboratories). The immunopreci-
pitated product was visualized with the AEC or DAB
reaction (Invitrogen, Darmstadt, Germany). For immu-
nofluorescence staining, Alexa Fluor 488 and/or Alexa
Fluor 568 (both 1:500, Invitrogen) were used and con-
trols performed as published (Baertling et al. 2010).
Standard H&E stain was performed on deparaffinized
sections for the evaluation of apoptosis using well-
defined morphological criteria, such as condensed and
fragmented cell nuclei (Hesse et al. 2010; Kipp et al.
2011b). Subsequently, stained and processed sections were
documented with a Nikon ECLIPSE 80i microscope.
Fluorescence microscopy was performed using the micro-
scope working station Zeiss LSM 7 Duo (Zeiss, Germany).
Counting was performed by two independent readers
blinded for treatment groups; the results were averaged.
Cell numbers are given in cells per square millimeter. For
the corpus callosum, cell parameters were quantified in both
the medial and lateral parts and the values averaged. For the
cortex, cell parameters were quantified on the same level in
the outer (layers 1–3) and inner parts (layers 4–6) and the
values averaged. Determination of cell area was performed
using NIS Elements 3.0 software (Nikon Corp., Japan). Cell
areas were measured using the auto-detect area tool. Area
was determined for 15 cells in each indicated region.
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Real-Time Reverse Transcriptase Polymerase Chain
Reaction
Gene expression levels were determined using the rt-PCR
technology (BioRad, Germany), QTM SYBR Green
Supermix (Quantace, Germany), and a standardized proto-
col as described previously (Kipp et al. 2011a; Groebe et al.
2009; Braun et al. 2009). Isolation of total RNA was per-
formed using the NucleoSpin kit (Macherey-Nagel,
Germany). RNA was reverse-transcribed using an M-MLV
RT kit and random hexanucleotide primers (both
Invitrogen). PCR reactions were carried out in a reaction
mixture consisting of 2 μl cDNA, 2 μl RNAse-free water,
5 μl QTM SYBR Green Supermix, and 0.5 μl of each
primer (10 pmol/μl) in standard 96-well plates under the
following conditions: 10 min enzyme activation at 95°C, 40
cycles of 15 s denaturation at 95°C, 30 s annealing at
individual temperatures, 30 s amplification at 72°C, and
5 s fluorescence measurement at 80°C. Primer sequences
are given in Table 1. Melting curves and gel electrophoresis
of the PCR products were routinely performed to determine
the specificity of the PCR reaction (not shown).
Relative quantification was performed by comparing the
Ct values of samples with the Ct values of an internal
standard curve, ranging from 100 % (undiluted) to 1.56 %
(seven times, 1:1 dilution). The results were normalized
using the ΔCt method, which results in ratios between the
target genes and a housekeeping reference gene (18s). As
the validity of this method critically depends on the constant
expression of the housekeeping gene, constant expression of
18s was verified (not shown).
To calculate the semiquantitative expression ratios be-
tween the corpus callosum and cortex, additional cDNA
was generated by reverse transcription of the control group
samples from the corpus callosum and the cortex in one
reverse transcription reaction. After subsequent PCR analy-
sis of 18s expression in these samples, differences in the
expression between the corpus callosum and the cortex in
control animals were calculated for Ccl2 and Ccl3. This
ΔΔCt calculation was done using REST-2009 software
(Pfaffl et al. 2002). Knowing the differences between the
controls enabled us to calculate expression differences for
the 1-week samples since the expression data for each
region are expressed relative to the control.
Statistical Analysis
Data represent the results of at least two independent experi-
ments. Statistics were made using absolute data of all
experiments. For IHC as well as rt-PCR, differences be-
tween groups were tested using ANOVA followed by
Tukey’s post hoc test. GraphPad Prism 5 (GraphPad
Software Inc.) was used. The statistical significance of the
difference of each group compared to the control is indicat-
ed (*p≤0.05; **p≤0.01; ***p≤0.001). All data are given as
arithmetic means±SEM. At least three mice each for IHC
and four mice each for gene expression analysis were used
per experimental group.
Results
Oligodendrocyte Loss Starts Early in the Cuprizone Model
Cuprizone ingestion in mice induces a highly reproducible
demyelination of distinct brain regions, among them the
white matter tract corpus callosum (CC) and the telence-
phalic gray matter Cx region (Kipp et al. 2009; Skripuletz et
al. 2008). In a first set of experiments, we aimed to inves-
tigate the temporal dynamics of oligodendrocyte loss, de-
myelination, microglia activation, and astrocytosis during
cuprizone intoxication. Mice were fed up to 5 weeks cupri-
zone and killed at half a week (i.e., 2 days), weeks 1, 2, 3,
and 5 after initiation of the cuprizone diet. Brain sections
were immunohistochemically stained for the myelin marker
protein PLP, the oligodendrocyte cell body marker APC, the
(activated) astrocyte-specific protein GFAP, and the
microglia/macrophage marker protein IBA1.
Regions included in the study are the CC (medial and
lateral parts) and the somatosensory Cx region (areas high-
lighted in Fig. 1a by red inserts). As demonstrated, oligo-
dendrocyte death starts early after initiation of the cuprizone
diet. Numerous apoptotic oligodendrocytes (i.e., condensed
and/or fragmented nuclei of cells in a chain-like formation;
Fig. 1a, red arrow) were seen after 2 days in the CC of
cuprizone-fed animals, whereas myelination, as determined
by anti-PLP staining, was still normal (see Fig. 1c). The
apoptotic nature of these cells was verified by anti-active
caspase 3 staining (Fig. 1a, lower left part). To further
confirm that oligodendrocytes undergo apoptotic cell death,
we stained for activated caspase 3 combined with immuno-
histochemistry for CNPase. As demonstrated, activated
Table 1 Primer sequences
Primer Sequence Length (bp) AT (°C)
18S cggctaccacatccaaggaa 187 60
gctggaattaccgcggct
Gfap cagatgatggagctcaatgacc 379 60
ctggatctcctcctccagcga
Plp tggcgactacaagaccacca 115 60
gacacacccgctccaaagaa
Ccl2 ttaaaaacctggatcggaaccaa 120 60
gcattagcttcagatttacgggt
Ccl3 ttctctgtaccatgacactctgc 99 62
cgtggaatcttccggctgtag
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caspase 3-expressing cells can be found in close vicinity to
CNPase-reactive fibers (Fig. 1a, lower right, white arrow).
Not only in the CC but also in the Cx region were apoptotic
cells observed, although in reduced numbers as compared to
the white matter tract CC. Furthermore, the morphology of
dying oligodendrocytes in the Cx region was slightly
different. The nuclei were condensed, but only rarely
fragmented nuclei were observed (Fig. 1a, blue arrow).
Control animals were lacking those cells. In parallel, we
found a marked decrease in the number of APC+ oligo-
dendrocytes in both regions (Fig. 1b). Already after
2 days of cuprizone intoxication, the numbers of APC+mature
oligodendrocytes were significantly decreased in both
regions included in the study. Myelination, as deter-
mined by anti-PLP IHC, was still normal at weeks 1–
2. At week 3, however, both regions displayed signifi-
cant loss of anti-PLP immunoreactivity. At week 5, both
regions were almost completely devoid of PLP-reactive
fibers (Fig. 1c). Furthermore, we investigated the effects
of cuprizone treatment on PLP gene expression sepa-
rately for both regions. As shown in Fig. 1d, Plp
mRNA expression levels showed a marked reduction
Fig. 1 a HE-stained sections of the midline of the corpus callosum in
control and 2 days cuprizone-treated animals as well as a 2-day cortex
sample. On day 2 after the start of the cuprizone diet, cells with the
typical morphological characteristics of apoptosis, such as round, con-
densed, and fragmented nuclei, were detected in both regions (red and
blue arrows). The apoptotic nature was further verified by anti-caspase
3 staining (lower left) and anti-caspase 3/CNPase double labeling
(lower right). b Left part Anti-APC stained sections of the midline of
the corpus callosum as well as cortex regions of a control animal and
after 5 weeks of cuprizone exposure. Right part Results of APC-
expressing cell quantification within the corpus callosum and cortex
regions. c Anti-PLP-stained sections of the midline of the corpus
callosum and cortex regions in control and 2 days and 1, 3, and 5 weeks
cuprizone-treated animals. Note that no overt loss of PLP staining
intensity can be observed until week 1 in both regions included in
the study, whereas the midline of the corpus callosum and the cortex
regions are significantly demyelinated at week 3. Demyelination fur-
ther progresses until week 5. d Results of Plp gene expression analysis
of the entire corpus callosum or cortex region. Each bar represents the
averaged fold induction over untreated control mice of at least four
mice per time point (±SEM). Values were normalized against a house-
keeping gene (18s) and expressed relative to the respective control
levels. *p≤0.05; **p≤0.01; ***p≤0.001 treatment vs. control. Scale
bars, 15 μm (upper part in a); 10 μm (lower left in a); 5 μm (lower
right in a); 50 μm (b); and 80 μm (c)
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already after 2 days in both regions and remained at
these low levels during the entire investigation period.
The observed early decline of PLPmRNA species suggests an
active down-regulation of oligodendrocyte-related gene
transcription.
Microglia Activation Is Evident Before Overt
Demyelination
In the cuprizone model, loss of oligodendrocytes involves
the expansion and activation of microglia cells and
astrocytes (Kipp et al. 2009, 2011a, b). In a next step,
we aimed to characterize the extent and dynamics of
microglia activation during the early and late stages of
cuprizone-induced demyelination. To this end, we quan-
tified the number of microglia cells in IBA1-stained
sections in the CC and Cx. Furthermore, the mean
microglia volume was estimated by measuring the surface
area covered by IBA1-expressing cells. As demonstrated
in Fig. 2, we observed an increase in IBA1+ cell numb-
ers in the CC after the earliest time point included in
the study (2 days). Thereafter, the number of microglia
steadily increased until week 5. Microgliosis was less
pronounced and delayed in the Cx. Furthermore, a
marked hypertrophy of IBA1+ cells was evident in the
CC after 1 week of cuprizone treatment. The increase in
microglia cell size was by far less distinctive in the
cortical gray matter (Fig. 2c, lower part).
The same cellular parameters were determined for GFAP-
expressing cells to assess the extent of astrocytosis. The
number of GFAP+ astrocytes was higher in the CC com-
pared to the Cx in control animals (Fig. 3a, c). During
cuprizone-induced demyelination, GFAP+ cell numbers
increased in both regions. Absolute numbers of GFAP-
expressing astrocytes in the CC exceeded those in the
Cx at any time point included in the study. Astroglia
volume was equal in the CC and Cx regions in untreat-
ed controls and evenly increased during the course of
cuprizone-induced demyelination (Fig. 3c, lower part).
Furthermore, we investigated the effects of cuprizone
treatment on Gfap gene expression (Fig. 3d). Within
the CC, Gfap mRNA expression was significantly up-
regulated at weeks 3 and 5 compared to the controls. A
significant induction of Gfap mRNA expression levels
within the Cx was evident already after week 1.
In summary, both regions display severe early oligo-
dendrocyte cell loss, isochronous microgliosis, followed
by astroglia activation and myelin loss. The extent of
the brain-intrinsic cellular inflammatory response is by
far greater within the affected white matter tract CC
compared to the demyelinated cortex region. Furthermore,
microgliosis in the white matter CC is clearly evident at
week 1, while myelination is still normal (Figs. 1c and 2a, c).
Ccl2 (Mcp1) and Ccl3 (Mip1α) Expression Up-regulation
Occurs Early in Cuprizone-Induced Demyelination
CCL2 and CCL3 are among the best characterized chemo-
kines. Previous studies revealed that both peptides might be
involved in MS pathology (McManus et al. 1998; Okada et
al. 2010). Since studies of the cellular infiltrate displayed
that the dynamics and extent of microgliosis at the site of
lesion differs between the white and gray matter, we spec-
ulated that the induction of chemokine expression displays a
region-specific kinetic/magnitude, as well. Therefore, rt-
PCR analyses for Ccl2 and Ccl3 were separately performed
in dissected CC and Cx samples during a 5-week cuprizone
exposure period. During cuprizone-induced demyelination,
two expression profiles were evident. Ccl2 mRNA expres-
sion in CC and the Cx peaked at week 1, but thereafter
appeared to be reduced (Fig. 4a). In contrast, Ccl3 mRNA
expression gradually increased in both regions (Fig. 4b).
The extent of chemokine expression induction was by far
greater within the Cx compared to the CC. Figure 4c
displays a comparative evaluation of the expression levels
between the CC and Cx regions at a given time point (i.e.,
control and 1 week). This analysis revealed that the basal
expression of Ccl3 is 25 times higher in the CC compared to
the Cx. For Ccl2, the mRNA levels are 333.3 times higher in
the CC compared to the Cx. At week 1, Ccl3 mRNA
levels are 1.3 times higher in the CC compared to the
Cx. For Ccl2, the mRNA levels are 28.1 times higher in
the CC compared to the Cx at week 1.
Discussion
In this study, we were able to demonstrate that cuprizone
treatment affects oligodendrocyte viability and, in conse-
quence, myelin integrity in the white matter tract CC and
the telencephalic gray matter region. These results are in line
with previously reported findings. Skripuletz et al. (2008)
were the first to demonstrate that in addition to the expected
demyelination in the CC, the cortex of C57BL/6 mice is
completely demyelinated after acute cuprizone-induced de-
myelination. In line with their findings, numbers of IBA1-
expressing microglia were not significantly increased in the
affected cortex region. However, we are now able to dem-
onstrate by means of morphometric estimation of the micro-
glia volume that this cell population is indeed activated in
both regions, although an increase in microglia cell size was
by far less distinctive in the cortical gray matter compared to
the white matter tract CC.
In MS, the pathology of gray matter lesions is believed to
differ from white matter lesions in several aspects, such as
less pronounced lymphocyte infiltration, macrophage activ-
ity, complement composition, or BBB alterations (Bo et al.
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2003; Breij et al. 2008; van Horssen et al. 2007; Peterson et
al. 2001). The observed differences could be due to the
differences in the composition and function of the BBB or
other elements of the cytoarchitecture of the cerebral Cx,
which makes it more resistant to inflammation (Bo et al.
2003). Whether or not the development of cortical demyeli-
nated lesions in MS displays a separate identity remains to
be clarified. In the cuprizone model, one would specu-
late that the underlying mechanism of oligodendrocyte
pathology does not differ between both regions. The
lower magnitude of microglia activation within the gray
matter cortex might be due to the differences in the
cortical cytoarchitecture. However, the reduced inflam-
matory response in cortical lesions, especially microglia/
macrophage activation, could be simply due to the lower
cortical myelin content and, in consequence, less myelin
debris during a demyelinating event. The same might be true
for less pronounced astrogliosis; however, systematic studies
addressing this issue were not yet performed.
Another important finding of this study was that in
the toxic demyelination cuprizone model, oligodendrog-
lial cell death and a reduction of myelin gene expres-
sion levels start days after the initiation of the cuprizone
diet and weeks before demyelination is evident. This
observation is in line with a study of Hesse et al. (2010) who
were further able to demonstrate that in the early but
not in the later stages, dying oligodendrocytes express
activated caspase 3, suggesting a switch from classical
Fig. 2 a Anti-IBA1-stained sections of the midline of the corpus
callosum and cortex regions in control and 2 days and 1, 3, and 5 weeks
cuprizone-treated animals. Note the early increase in microglia cell
numbers at day 2 and the pronounced increase at week 5, respectively.
b Higher magnification micrographs of IBA1-positive cells within the
midline of the corpus callosum and cortex regions in control animals
and after 5 weeks cuprizone treatment. Note the pronounced increase
in number and size after 5 weeks within the midline of the corpus
callosum. c Upper row Results of IBA1-expressing cell quantification
within the corpus callosum and cortex regions. Lower row Morpho-
metric quantification of IBA1-expressing cell area within the corpus
callosum and cortex regions. Note that microglia hyperplasia and
hypertrophy are more pronounced in the affected white matter corpus
callosum compared to the gray matter cortex region. *p≤0.05; **p≤
0.01; ***p≤0.001 treatment vs. control. Scale bars, 50 μm (a) and
15 μm (b)
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apoptotic pathways to caspase 3-independent mecha-
nisms during the course of the cuprizone diet. We are
the first to demonstrate that early oligodendrocyte loss
is not only restricted to the CC but can also be ob-
served in the cortex region. Both the number of APC-
expressing oligodendrocytes as well as the Plp mRNA
levels are dramatically reduced in both regions included
in this study at week 1. The phenomenon of oligodendrocyte
apoptosis/stress and microglia activation in a normally mye-
linated tissue (at least if investigated by conventional immu-
nohistochemistry) has also been described in MS tissue. In
2001, the Amsterdam Neuropathology Group described the
selection of MS lesions for further characterization using a
novel MRI-guided sampling protocol (De Groot et al. 2001).
This novel protocol revealed lesion-like signals on MRI scans
that were not the traditional MS lesions upon routine
histological examination. Subsequent histological analysis of
these lesions has led to the realization that the abnormalities
seen by MRI correlated with the well-circumscribed clusters
of activated microglial cells, notably in the absence of
demyelination, i.e., in otherwise normal-appearing white
matter. The activated state of the microglia was reflected
by the increased expression of HLA-DR and CD68. The
authors termed the observed abnormalities “pre-active”
lesions due to the assumption that they precede classical
active demyelinating lesions, at least in a subset of
patients (van der Valk and De Groot 2000; van der
Valk and Amor 2009; van Noort et al. 2011). The
general awareness of pre-active lesions as a real phenomenon
in MS is surprisingly limited. This may have something to do
with the fact that the several studies that have documented
them in great detail all use different terms to describe them.
Fig. 3 a Upper row Anti-GFAP-stained sections of the midline of the
corpus callosum in control and 2 days and 1, 3, and 5 weeks cuprizone-
treated animals. Note the severe astrocytosis at week 5. Lower row
Anti-GFAP-stained sections of the cortex in control and 2 days and 1,
3, and 5 weeks cuprizone-treated animals. Note the moderate increase
in GFAP+ cell numbers at week 5. b Micrographs in higher magnifi-
cation of GFAP+ cells within the midline of the corpus callosum and
cortex regions in control animals and after 5 weeks cuprizone treat-
ment. Note the pronounced increase in number and size after 5 weeks
within the midline of the corpus callosum. c Upper row Results of
GFAP-expressing cell quantification within the corpus callosum and
cortex regions. Lower row Morphometric quantification of GFAP-
expressing cell area within the corpus callosum and cortex regions.
Note that the extent of astrocyte hypertrophy is comparable in the
affected white matter corpus callosum and the gray matter cortex
region. d Results of Gfap gene expression analysis of the entire corpus
callosum or cortex region. Each bar represents the averaged fold
induction over untreated control mice of at least four mice per time
point (±SEM). *p≤0.05; **p≤0.01; ***p≤0.001 treatment vs. control.
Scale bars, 50 μm (a) and 15 μm (b)
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The first study called them “type I lesions” (Gay 2006), the
second “(p)re-active lesions” (De Groot et al. 2001), and the
third “newly forming lesions” (Barnett and Prineas 2004),
while more recently they were called “pattern III lesions”
(Marik et al. 2007). Yet, they all refer to the same phenome-
non. We speculate that short-term cuprizone exposure models
very well such early pathological stages during MS lesion
formation (Kipp et al. 2011b), and analyzing the affected CC
in detail might help in understanding the underlying mecha-
nisms and the relevance of early microglia activation in MS
pathogenesis and disease progression.
CCL2 (MCP1) and CCL3 (MIP-1α) are among the best
characterized chemokines. Previous studies revealed that both
chemokinesmight be involved inMS pathology. For example,
in experimental autoimmune neuritis, administration of anti-
CCL2 antibodies delayed the onset of the disease (Zou et al.
1999). Anti-CCL2 significantly reduced the severity of relaps-
ing EAE (Karpus and Kennedy 1997). CCL3 expression
correlated with acute disease development, whereas CCL2
did not. In contrast, CCL2 production in the CNS correlated
with relapsing EAE development. Moreover, anti-CCL3
inhibited the development of acute but not relapsing EAE.
During this study, analyses of chemokine gene expression
levels revealed that Ccl2 and Ccl3 mRNA levels significantly
increased in both regions. Interestingly, Ccl2 induction was a
transient phenomenon, whereas the mRNA levels for Ccl3
continuously increased. One might speculate that CCL2medi-
ates early microglia activation, whereas the function of CCL3
orchestrates later cellular events such as the induction of
astrocyte activation and/or sustenance of microgliosis.
Fig. 4 a, b Results of Ccl2 (a)
and Ccl3 (b) gene expression
analysis by rt-PCR of the entire
corpus callosum or cortex re-
gion. Each bar represents the
averaged fold induction over
untreated control mice of at
least four mice per time point
(±SEM). Values were normal-
ized against a housekeeping
gene (18s) and expressed rela-
tive to the respective control
levels. Note the early induction
of Ccl2 and Ccl3 mRNA
expression levels. c mRNA
expression ratio CC vs. Cx in
control animals and after
1 week cuprizone exposure for
Ccl2 and Ccl3. Note that the
basal mRNA levels of Ccl2 are
333.3 times greater and those of
Ccl3 are 25 times greater in the
corpus callosum compared to




74 J Mol Neurosci (2012) 48:66–76
Remarkably, comparative analysis revealed that Ccl2 and,
although to a lesser extent, Ccl3 levels are, at least on the
mRNA level, greater in the CC compared to the cortex region.
This finding strongly suggests that both chemokines somehow
mediate lower inflammatory infiltrates in demyelinated gray
matter lesions. Further studies have to show the functional
relevance of early CCL2 expression in this animal model, the
impact of sustained CCL3 levels on astrocyte activation and
maybe myelin repair, which is evident in the later stages (Kipp
et al. 2009, 2011a, c), and the source of respective chemokines
on the cellular level.
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